Skip to content

Asset Entities ASST Medical device revenues — Total revenues

Other product segments

Investment advisory fees
$1.35M-4.9%

Similar metrics at other companies

Agilon Health logo
AGLMedical services revenue — Total revenues
$1.42B-7.3%
Bausch + Lomb logo
BLCODevices — Total revenues
$480M+7.1%
Gentex logo
GNTXMedical Products — Total Revenue
$353.62K-8.6%
Mirion Technologies logo
MIRMedical Segment — Total revenues
$72.1M+5.1%
iRadimed logo
IRMDTotal devices revenue — Total Revenue
$15.39M+18.7%
Omnicell logo
OMCLConnected devices, software licenses, and other — Total revenues
$148.66M+23.8%

Other financials

Income statement

See full
Revenue$2.8M+1,516%
Operating income-$313.1M-7,588%
Net income-$265.9M-6,993%
EPS (diluted)-$4.53-175%

Balance sheet

See full
Cash & equivalents$95.1M+982%
Total debt$3.4M
Total equity$714.8M+3,548%
Total assets$1.1B+21,931%

Cash flow

See full
Operating cash flow-$31.0M-455%
CapEx--100%
Free cash flow-$31.0M-450%

Valuation

See full
Market cap$1.02B+1,127%
Enterprise value$932M
P/S118.1×

Profitability

See full
Operating margin-6,563%-18,545pp
Net margin-8,022.9%-20,291pp
FCF margin-3,856.7%

Returns & leverage

See full
Return on equity-189.4%+139pp
Debt / equity
Current ratio11.4×+1.7×

Where this comes from

Reported directly by Asset Entities in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Asset Entities’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Asset Entities's medical device revenues — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Asset Entities's medical device revenues — total revenues?
Asset Entities (ASST) reported medical device revenues — total revenues of $1.37M in Q1 2026.
What does medical device revenues — total revenues mean?
This metric represents the proportion of total consolidated revenue derived specifically from medical device-related services or product offerings. It serves as a key indicator of the company's diversification into the healthcare technology sector and its ability to monetize specialized technical expertise outside of its core social media and digital marketing operations. Tracking this segment helps investors assess the growth trajectory and revenue contribution of the company's non-core business initiatives.